Skip to main content
. 2022 Sep 28;13:965905. doi: 10.3389/fimmu.2022.965905

Figure 6.

Figure 6

mRMR analysis according to therapy. (A) Distribution and classification from differential profiles of soluble receptors and immune checkpoints. (B) Boxplot sIL-2R in serum across the analyzed cohort.